Annovis Bio (ANVS) Proxy Filing summary

Executive summary

• The annual meeting is scheduled for June 17, 2025, and will be held virtually, allowing shareholders to vote and ask questions online using a unique control number.

• Proxy materials are distributed primarily via the Internet to expedite delivery, reduce costs, and conserve resources, with paper copies available upon request.

• Shareholders of record as of April 28, 2025, are entitled to vote on the election of five directors and the ratification of Ernst & Young LLP as the independent auditor for 2025.

• The Board recommends voting in favor of all director nominees and the auditor ratification.

Voting matters and shareholder proposals

• Shareholders will vote on the election of five directors and the ratification of Ernst & Young LLP as the independent registered public accounting firm for 2025.

• The Board unanimously recommends voting “FOR” all director nominees and the auditor ratification.

• Shareholders may submit proposals for the 2026 annual meeting by December 31, 2025, following specific procedures outlined in the bylaws.

Board of directors and corporate governance

• The Board consists of five members, with Michael Hoffman as Chairman and Maria Maccecchini as President and CEO.

• Three directors (Hoffman, Bruck, McCarthy) are considered independent under NYSE and SEC rules.

• The Board has Audit, Compensation, and Nominating Committees, all composed of independent directors.

• Leadership structure separates the roles of Chairman and CEO, with flexibility to change as needed.

• The Board held six meetings in 2024, with all directors attending at least 75% of meetings.